Ibrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection). Reference standards of Ibrexafungerp Citrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ibrexafungerp Citrate
Catalogue No.:PA 09 1320000
CAS :
Molecular Formula : C50H75N5O11
Molecular Weight : 922.17
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....